Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Bailey Evan Prescott | Chief Medical Officer | 6 | $0 | $0 | 2026-02-03 |
| Chinoporos Constantine | See Remarks | 7 | $0 | $17.3K | 2026-02-03 |
| Kanter Stacy J. | Director | 26 | $509.7K | $4.7K | 2026-02-03 |
| Lerner Teena | Director | 29 | $0 | $0 | 2026-02-03 |
| Funtleyder Leslie D. | See Remarks | 85 | $0 | $5.27M | 2026-02-03 |
| Hooks Corwin Dale | Chief Commercial Officer | 5 | $0 | $0 | 2026-02-03 |
| SKYLER JAY S | Director | 22 | $0 | $0 | 2026-02-03 |
| Perfetti Riccardo | Chief Medical Officer | 210 | $125.8K | $3.22M | 2025-03-04 |
| JOHNSON JOHN | Executive Chairman | 2 | $0 | $0 | 2024-12-19 |
| Shendelman Shoshana | President and CEO | 76 | $1.49M | $15.00M | 2024-08-14 |
| MARCUS JOEL S | Director | 50 | $1.52M | $1.78M | 2024-06-06 |
| Alexandria Equities No. 7, LLC | 10% Owner | 10 | $9.75M | $2.05M | 2024-06-05 |
| Hansard Adam | Chief Commercial Officer | 26 | $0 | $348.8K | 2024-03-14 |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | 10% Owner | 7 | $1000.0K | $572.2K | 2023-11-03 |
| Alexandria Venture Investments, LLC | 10% Owner | 12 | $5.00M | $0 | 2023-10-12 |
| Ortega Steven A. | Principal Accounting Officer | 3 | $0 | $0 | 2022-11-15 |
| Mahadevan Chids | See Remarks | 11 | $0 | $1.5K | 2022-08-02 |
| Silberstein Charles | Chief Financial Officer | 9 | $0 | $108.1K | 2022-01-07 |
| Vignola Mark J. | Chief Financial Officer | 1 | $0 | $0 | 2019-05-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Lerner Teena | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 10,230 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 20,460 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 23,941 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 200,000 | — | $0 | 0 | SEC↗ |
| Bailey Evan Prescott | Chief Medical Officer | D To issuer deriv | 2026-02-03 | 2026-02-03 | 4,883 | — | $0 | 0 | SEC↗ |
| Bailey Evan Prescott | Chief Medical Officer | D To issuer deriv | 2026-02-03 | 2026-02-03 | 19,531 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | D To issuer deriv | 2026-02-03 | 2026-02-03 | 20,460 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | D To issuer deriv | 2026-02-03 | 2026-02-03 | 150,000 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | D To issuer deriv | 2026-02-03 | 2026-02-03 | 40,502 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | D To issuer deriv | 2026-02-03 | 2026-02-03 | 10,230 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 16,500 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 20,460 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 200,000 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2026-02-03 | 2026-02-03 | 10,230 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2026-02-03 | 2026-02-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2026-02-03 | 2026-02-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2026-02-03 | 2026-02-04 | 20,460 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2026-02-03 | 2026-02-04 | 200,000 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2026-02-03 | 2026-02-04 | 10,230 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | U Tender | 2026-02-03 | 2026-02-03 | 82,922 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer | 2026-02-03 | 2026-02-03 | 22,500 | — | $0 | 82,922 | SEC↗ |
| Bailey Evan Prescott | Chief Medical Officer | D To issuer | 2026-02-03 | 2026-02-03 | 1,235,915 | — | $0 | 60,901 | SEC↗ |
| Bailey Evan Prescott | Chief Medical Officer | U Tender | 2026-02-03 | 2026-02-03 | 60,901 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | U Tender | 2026-02-03 | 2026-02-03 | 152,959 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | D To issuer | 2026-02-03 | 2026-02-03 | 2,375,000 | — | $0 | 152,959 | SEC↗ |
| SKYLER JAY S | Director | U Tender | 2026-02-03 | 2026-02-03 | 42,500 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer | 2026-02-03 | 2026-02-03 | 22,500 | — | $0 | 42,500 | SEC↗ |
| Chinoporos Constantine | See Remarks | D To issuer | 2026-02-03 | 2026-02-03 | 1,000,000 | — | $0 | 57,111 | SEC↗ |
| Chinoporos Constantine | See Remarks | U Tender | 2026-02-03 | 2026-02-03 | 57,111 | — | $0 | 0 | SEC↗ |
| Hooks Corwin Dale | Chief Commercial Officer | U Tender | 2026-02-03 | 2026-02-03 | 5,753 | — | $0 | 0 | SEC↗ |
| Hooks Corwin Dale | Chief Commercial Officer | D To issuer | 2026-02-03 | 2026-02-03 | 862,500 | — | $0 | 5,753 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer | 2026-02-03 | 2026-02-04 | 22,500 | — | $0 | 42,500 | SEC↗ |
| Kanter Stacy J. | Director | U Tender | 2026-02-03 | 2026-02-04 | 42,500 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | A Award | 2026-01-01 | 2026-01-02 | 150,000 | — | $0 | 1,340,459 | SEC↗ |
| Bailey Evan Prescott | Chief Medical Officer | A Award | 2025-12-19 | 2026-02-03 | 437,500 | — | $0 | 1,296,816 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | A Award | 2025-12-19 | 2026-02-03 | 1,187,500 | — | $0 | 2,527,959 | SEC↗ |
| Chinoporos Constantine | See Remarks | A Award | 2025-12-19 | 2026-02-03 | 437,500 | — | $0 | 1,057,111 | SEC↗ |
| Hooks Corwin Dale | Chief Commercial Officer | A Award | 2025-12-19 | 2026-02-03 | 312,500 | — | $0 | 868,253 | SEC↗ |
| Kanter Stacy J. | Director | S Sale | 2025-12-16 | 2025-12-18 | 43,000 | $0.11 | $4.7K | 65,000 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | A Award | 2025-10-01 | 2025-10-01 | 150,000 | — | $0 | 1,190,459 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | A Award | 2025-07-01 | 2025-07-03 | 150,000 | — | $0 | 937,121 | SEC↗ |
| Bailey Evan Prescott | Chief Medical Officer | A Award | 2025-06-15 | 2025-06-17 | 300,000 | — | $0 | 841,669 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | A Award | 2025-06-09 | 2025-07-03 | 150,000 | — | $0 | 787,121 | SEC↗ |
| SKYLER JAY S | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Kanter Stacy J. | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Lerner Teena | Director | A Award deriv | 2025-06-09 | 2025-06-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Chinoporos Constantine | See Remarks | A Award | 2025-03-24 | 2025-03-26 | 350,000 | — | $0 | 621,436 | SEC↗ |
| Funtleyder Leslie D. | See Remarks | A Award | 2025-03-24 | 2025-03-26 | 350,000 | — | $0 | 740,459 | SEC↗ |
| Hooks Corwin Dale | Chief Commercial Officer | A Award | 2025-03-24 | 2025-03-26 | 250,000 | — | $0 | 550,000 | SEC↗ |
| Chinoporos Constantine | See Remarks | S Sale | 2025-03-04 | 2025-03-06 | 447 | $0.44 | $197 | 271,436 | SEC↗ |
| Funtleyder Leslie D. | See Remarks | S Sale | 2025-03-04 | 2025-03-06 | 14,502 | $0.44 | $6.4K | 390,459 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2025-03-04 | 2025-03-06 | 10,366 | $0.44 | $4.6K | 890,409 | SEC↗ |
| Chinoporos Constantine | See Remarks | S Sale | 2025-02-06 | 2025-02-07 | 28,117 | $0.61 | $17.2K | 271,883 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2025-02-06 | 2025-02-07 | 86,078 | $0.61 | $52.5K | 900,775 | SEC↗ |
| Funtleyder Leslie D. | See Remarks | S Sale | 2025-02-06 | 2025-02-07 | 22,950 | $0.61 | $14.0K | 404,961 | SEC↗ |
| Funtleyder Leslie D. | See Remarks | A Award deriv | 2024-12-19 | 2024-12-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| JOHNSON JOHN | Executive Chairman | A Award deriv | 2024-12-19 | 2024-12-20 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Funtleyder Leslie D. | See Remarks | A Award | 2024-12-19 | 2024-12-20 | 150,000 | — | $0 | 427,911 | SEC↗ |
| JOHNSON JOHN | Executive Chairman | A Award | 2024-12-19 | 2024-12-20 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2024-08-22 | 2024-08-23 | 22,681 | $5.83 | $132.2K | 986,853 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | S Sale | 2024-08-22 | 2024-08-23 | 13,530 | $5.83 | $78.9K | 277,911 | SEC↗ |
| Shendelman Shoshana | President and CEO | S Sale | 2024-08-14 | 2024-08-14 | 119,591 | $5.93 | $709.2K | 4,690,839 | SEC↗ |
| Shendelman Shoshana | President and CEO | S Sale | 2024-08-13 | 2024-08-14 | 357,423 | $6.18 | $2.21M | 4,810,430 | SEC↗ |
| Shendelman Shoshana | President and CEO | S Sale | 2024-08-12 | 2024-08-14 | 300,000 | $5.98 | $1.79M | 5,167,853 | SEC↗ |
| Shendelman Shoshana | President and CEO | G Gift | 2024-08-05 | 2024-08-14 | 747,886 | — | $0 | 747,886 | SEC↗ |
| Shendelman Shoshana | President and CEO | G Gift | 2024-08-05 | 2024-08-14 | 747,886 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | A Award | 2024-06-06 | 2024-06-07 | 45,000 | — | $0 | 105,422 | SEC↗ |
| MARCUS JOEL S | Director | A Award | 2024-06-06 | 2024-06-07 | 45,000 | — | $0 | 498,414 | SEC↗ |
| SKYLER JAY S | Director | A Award | 2024-06-06 | 2024-06-07 | 45,000 | — | $0 | 65,000 | SEC↗ |
| Kanter Stacy J. | Director | A Award | 2024-06-06 | 2024-06-07 | 45,000 | — | $0 | 108,000 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | S Sale | 2024-06-06 | 2024-06-10 | 16,980 | $4.32 | $73.4K | 291,441 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2024-06-06 | 2024-06-10 | 22,003 | $4.32 | $95.1K | 1,009,534 | SEC↗ |
| Shendelman Shoshana | President and CEO | S Sale | 2024-06-06 | 2024-06-10 | 61,795 | $4.32 | $267.0K | 3,756,019 | SEC↗ |
| Alexandria Equities No. 7, LLC | 10% Owner | S Sale | 2024-06-05 | 2024-06-06 | 150,000 | $4.24 | $636.0K | 5,855,077 | SEC↗ |
| Alexandria Equities No. 7, LLC | 10% Owner | S Sale | 2024-06-04 | 2024-06-06 | 150,000 | $4.21 | $631.5K | 6,005,077 | SEC↗ |
| Hooks Corwin Dale | Chief Commercial Officer | A Award | 2024-04-12 | 2024-04-15 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | S Sale | 2024-03-14 | 2024-03-18 | 28,727 | $5.39 | $154.8K | 308,421 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | S Sale | 2024-03-14 | 2024-03-18 | 48,871 | $5.39 | $263.4K | 732,919 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2024-03-14 | 2024-03-18 | 110,804 | $5.39 | $597.2K | 1,031,537 | SEC↗ |
| Shendelman Shoshana | President and CEO | S Sale | 2024-03-14 | 2024-03-18 | 318,573 | $5.39 | $1.72M | 3,817,814 | SEC↗ |
| Chinoporos Constantine | See Remarks | A Award | 2023-12-28 | 2024-03-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | A Award | 2023-12-21 | 2023-12-22 | 400,000 | — | $0 | 781,790 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | A Award | 2023-12-21 | 2023-12-22 | 450,000 | — | $0 | 1,142,341 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award | 2023-12-21 | 2023-12-22 | 1,100,000 | — | $0 | 3,696,387 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award | 2023-12-21 | 2023-12-22 | 440,000 | — | $0 | 4,136,387 | SEC↗ |
| Kanter Stacy J. | Director | P Buy | 2023-12-01 | 2023-12-05 | 30,000 | $2.18 | $65.4K | 63,000 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | S Sale | 2023-11-30 | 2023-12-01 | 965 | $1.97 | $1.9K | 381,790 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2023-11-30 | 2023-12-01 | 1,583 | $1.97 | $3.1K | 692,341 | SEC↗ |
| Shendelman Shoshana | President and CEO | S Sale | 2023-11-30 | 2023-12-01 | 3,968 | $1.97 | $7.8K | 2,596,387 | SEC↗ |
| Alexandria Equities No. 7, LLC | 10% Owner | J Other | 2023-11-29 | 2023-12-01 | 575,000 | — | $0 | 203,977 | SEC↗ |
| Alexandria Equities No. 7, LLC | 10% Owner | J Other | 2023-11-29 | 2023-12-01 | 575,000 | — | $0 | 6,155,077 | SEC↗ |
| Funtleyder Leslie D. | Chief Financial Officer | A Award | 2023-11-20 | 2023-11-20 | 300,000 | — | $0 | 337,148 | SEC↗ |
| ALEXANDRIA REAL ESTATE EQUITIE | 10% Owner | S Sale | 2023-11-03 | 2023-11-06 | 143,450 | $2.31 | $331.4K | 5,580,077 | SEC↗ |
| ALEXANDRIA REAL ESTATE EQUITIE | 10% Owner | S Sale | 2023-11-02 | 2023-11-06 | 103,808 | $2.32 | $240.8K | 5,723,527 | SEC↗ |
| Alexandria Equities No. 7, LLC | 10% Owner | S Sale | 2023-11-01 | 2023-11-02 | 172,742 | $2.36 | $407.7K | 5,827,335 | SEC↗ |
| Alexandria Equities No. 7, LLC | 10% Owner | S Sale | 2023-10-31 | 2023-11-02 | 155,000 | $2.41 | $373.6K | 6,000,077 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | J Other deriv | 2023-10-12 | 2023-10-16 | 615,000 | — | $0 | 1,500,000 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | J Other deriv | 2023-10-12 | 2023-10-16 | 615,000 | — | $0 | 0 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | J Other | 2023-10-12 | 2023-10-16 | 1,600,000 | — | $0 | 778,977 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | J Other | 2023-10-12 | 2023-10-16 | 1,600,000 | — | $0 | 6,155,077 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | S Sale | 2023-09-27 | 2023-09-29 | 9,720 | $2.70 | $26.2K | 382,755 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2023-09-27 | 2023-09-29 | 10,932 | $2.70 | $29.5K | 693,924 | SEC↗ |
| Shendelman Shoshana | President and CEO | S Sale | 2023-09-27 | 2023-09-29 | 115,632 | $2.70 | $312.2K | 2,600,355 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise deriv | 2023-09-15 | 2023-09-19 | 12,375 | — | $0 | 0 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise | 2023-09-15 | 2023-09-19 | 12,375 | $1.05 | $13.0K | 453,414 | SEC↗ |
| Funtleyder Leslie D. | Director | A Award | 2023-06-06 | 2023-06-08 | 20,000 | — | $0 | 37,148 | SEC↗ |
| Kanter Stacy J. | Director | A Award | 2023-06-06 | 2023-06-08 | 20,000 | — | $0 | 33,000 | SEC↗ |
| Lerner Teena | Director | A Award | 2023-06-06 | 2023-06-08 | 20,000 | — | $0 | 60,422 | SEC↗ |
| MARCUS JOEL S | Director | A Award | 2023-06-06 | 2023-06-08 | 20,000 | — | $0 | 441,039 | SEC↗ |
| SKYLER JAY S | Director | A Award | 2023-06-06 | 2023-06-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | S Sale | 2023-01-11 | 2023-01-13 | 4,495 | $0.91 | $4.1K | 92,475 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | A Award | 2023-01-11 | 2023-01-13 | 300,000 | — | $0 | 392,475 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2023-01-11 | 2023-01-13 | 6,053 | $0.91 | $5.5K | 154,856 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | A Award | 2023-01-11 | 2023-01-13 | 550,000 | — | $0 | 704,856 | SEC↗ |
| Shendelman Shoshana | President and CEO | S Sale | 2023-01-11 | 2023-01-13 | 15,870 | $0.91 | $14.4K | 751,625 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award | 2023-01-11 | 2023-01-13 | 1,964,362 | — | $0 | 2,715,987 | SEC↗ |
| Ortega Steven A. | Principal Accounting Officer | A Award | 2022-11-15 | 2022-11-17 | 40,000 | — | $0 | 55,404 | SEC↗ |
| Shendelman Shoshana | President and CEO | P Buy | 2022-10-14 | 2022-10-14 | 50,000 | $0.65 | $32.5K | 767,495 | SEC↗ |
| Shendelman Shoshana | President and CEO | P Buy | 2022-10-13 | 2022-10-13 | 73,256 | $0.56 | $41.0K | 717,495 | SEC↗ |
| Shendelman Shoshana | President and CEO | P Buy | 2022-10-12 | 2022-10-12 | 38,153 | $0.52 | $19.8K | 644,239 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise deriv | 2022-09-14 | 2022-09-16 | 4,125 | — | $0 | 12,375 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise deriv | 2022-09-14 | 2022-09-16 | 16,500 | — | $0 | 0 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise deriv | 2022-09-14 | 2022-09-16 | 10,230 | — | $0 | 0 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise deriv | 2022-09-14 | 2022-09-16 | 7,389 | — | $0 | 0 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise | 2022-09-14 | 2022-09-16 | 10,230 | $1.05 | $10.7K | 400,414 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise | 2022-09-14 | 2022-09-16 | 7,389 | $1.05 | $7.8K | 390,184 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise | 2022-09-14 | 2022-09-16 | 16,500 | $1.05 | $17.3K | 416,914 | SEC↗ |
| MARCUS JOEL S | Director | M Exercise | 2022-09-14 | 2022-09-16 | 4,125 | $1.05 | $4.3K | 421,039 | SEC↗ |
| Funtleyder Leslie D. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Funtleyder Leslie D. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Funtleyder Leslie D. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 0 | SEC↗ |
| Funtleyder Leslie D. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 10,230 | SEC↗ |
| Funtleyder Leslie D. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 20,460 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 21,100 | — | $0 | 21,100 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 104,665 | — | $0 | 104,665 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 104,665 | — | $0 | 0 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 21,100 | — | $0 | 21,100 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 21,100 | — | $0 | 0 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 32,339 | — | $0 | 32,339 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 21,100 | — | $0 | 0 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 32,339 | — | $0 | 0 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 50,000 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 20,460 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 10,230 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Kanter Stacy J. | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 20,460 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 10,230 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Lerner Teena | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Mahadevan Chids | See Remarks | D To issuer deriv | 2022-08-02 | 2022-08-04 | 19,058 | — | $0 | 19,058 | SEC↗ |
| Mahadevan Chids | See Remarks | D To issuer deriv | 2022-08-02 | 2022-08-04 | 19,058 | — | $0 | 0 | SEC↗ |
| Mahadevan Chids | See Remarks | D To issuer deriv | 2022-08-02 | 2022-08-04 | 7,264 | — | $0 | 0 | SEC↗ |
| Mahadevan Chids | See Remarks | D To issuer deriv | 2022-08-02 | 2022-08-04 | 7,264 | — | $0 | 7,264 | SEC↗ |
| Mahadevan Chids | See Remarks | D To issuer deriv | 2022-08-02 | 2022-08-04 | 8,824 | — | $0 | 0 | SEC↗ |
| Mahadevan Chids | See Remarks | D To issuer deriv | 2022-08-02 | 2022-08-04 | 8,824 | — | $0 | 8,824 | SEC↗ |
| MARCUS JOEL S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 10,230 | SEC↗ |
| MARCUS JOEL S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 7,389 | — | $0 | 0 | SEC↗ |
| MARCUS JOEL S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MARCUS JOEL S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 0 | SEC↗ |
| MARCUS JOEL S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MARCUS JOEL S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| MARCUS JOEL S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 7,389 | — | $0 | 7,389 | SEC↗ |
| MARCUS JOEL S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 36,495 | — | $0 | 36,495 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 32,100 | — | $0 | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 32,100 | — | $0 | 32,100 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 32,100 | — | $0 | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 36,495 | — | $0 | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 32,100 | — | $0 | 32,100 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 51,666 | — | $0 | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 51,666 | — | $0 | 51,666 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 134,997 | — | $0 | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 134,997 | — | $0 | 134,997 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | D To issuer deriv | 2022-08-02 | 2022-08-04 | 50,000 | — | $0 | 0 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 607,484 | — | $0 | 607,484 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 607,484 | — | $0 | 0 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 23,317 | — | $0 | 23,317 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 23,317 | — | $0 | 0 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 134,979 | — | $0 | 134,979 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 134,979 | — | $0 | 0 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 101,670 | — | $0 | 101,670 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 101,670 | — | $0 | 0 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 234,616 | — | $0 | 234,616 | SEC↗ |
| Shendelman Shoshana | President and CEO | D To issuer deriv | 2022-08-02 | 2022-08-04 | 234,616 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 20,460 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 20,460 | — | $0 | 0 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 10,230 | — | $0 | 10,230 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 16,500 | SEC↗ |
| SKYLER JAY S | Director | D To issuer deriv | 2022-08-02 | 2022-08-04 | 16,500 | — | $0 | 0 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | P Buy deriv | 2022-06-27 | 2022-06-29 | 2,950,000 | — | $0 | 2,950,000 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | P Buy deriv | 2022-06-27 | 2022-06-29 | 2,050,000 | — | $0 | 2,050,000 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | P Buy deriv | 2022-06-27 | 2022-06-29 | 615,000 | $1.00 | $615.0K | 615,000 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | P Buy deriv | 2022-06-27 | 2022-06-29 | 885,000 | $1.00 | $885.0K | 885,000 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | P Buy | 2022-06-27 | 2022-06-29 | 1,435,000 | $1.00 | $1.44M | 2,378,977 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | P Buy | 2022-06-27 | 2022-06-29 | 2,065,000 | $1.00 | $2.06M | 4,555,077 | SEC↗ |
| Funtleyder Leslie D. | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Kanter Stacy J. | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Lerner Teena | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MARCUS JOEL S | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| SKYLER JAY S | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 16,500 | — | $0 | 16,500 | SEC↗ |
| Mahadevan Chids | See Remarks | S Sale | 2022-05-16 | 2022-05-18 | 905 | $1.65 | $1.5K | 9,800 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | A Award deriv | 2022-04-13 | 2022-04-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Mahadevan Chids | See Remarks | A Award deriv | 2022-04-13 | 2022-04-15 | 19,058 | — | $0 | 19,058 | SEC↗ |
| Ortega Steven A. | Principal Accounting Officer | A Award deriv | 2022-04-13 | 2022-04-15 | 10,675 | — | $0 | 10,675 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | A Award deriv | 2022-04-13 | 2022-04-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Mahadevan Chids | See Remarks | A Award | 2022-04-13 | 2022-04-15 | 2,136 | — | $0 | 10,705 | SEC↗ |
| Ortega Steven A. | Principal Accounting Officer | A Award | 2022-04-13 | 2022-04-15 | 3,081 | — | $0 | 15,404 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | P Buy | 2022-03-23 | 2022-03-23 | 30,000 | $1.97 | $59.1K | 160,909 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | P Buy | 2022-03-22 | 2022-03-23 | 21,961 | $1.98 | $43.5K | 130,909 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | P Buy | 2022-03-21 | 2022-03-23 | 12,548 | $1.85 | $23.2K | 108,948 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | J Other | 2022-02-23 | 2022-02-25 | 300,000 | — | $0 | 2,490,077 | SEC↗ |
| Alexandria Venture Investments | 10% Owner | J Other | 2022-02-23 | 2022-02-25 | 300,000 | — | $0 | 943,977 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award deriv | 2022-01-25 | 2022-01-27 | 234,616 | — | $0 | 234,616 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 21,100 | — | $0 | 21,100 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 32,100 | — | $0 | 32,100 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award deriv | 2022-01-07 | 2022-01-11 | 80,600 | — | $0 | 80,600 | SEC↗ |
| Silberstein Charles | Chief Financial Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | A Award | 2022-01-07 | 2022-01-11 | 31,700 | — | $0 | 96,970 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | A Award | 2022-01-07 | 2022-01-11 | 48,200 | — | $0 | 96,400 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award | 2022-01-07 | 2022-01-11 | 120,900 | — | $0 | 606,086 | SEC↗ |
| Silberstein Charles | Chief Financial Officer | A Award | 2022-01-07 | 2022-01-11 | 47,900 | — | $0 | 183,603 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | A Award | 2021-12-14 | 2022-01-11 | 31,700 | — | $0 | 65,270 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | A Award | 2021-12-14 | 2022-01-11 | 48,200 | — | $0 | 48,200 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award | 2021-12-14 | 2022-01-11 | 120,900 | — | $0 | 485,186 | SEC↗ |
| Silberstein Charles | Chief Financial Officer | A Award | 2021-12-14 | 2022-01-11 | 47,900 | — | $0 | 135,703 | SEC↗ |
| Silberstein Charles | Chief Financial Officer | A Award deriv | 2021-12-14 | 2021-12-16 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | A Award deriv | 2021-12-14 | 2021-12-16 | 21,100 | — | $0 | 21,100 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | A Award deriv | 2021-12-14 | 2021-12-16 | 32,100 | — | $0 | 32,100 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award deriv | 2021-12-14 | 2021-12-16 | 80,600 | — | $0 | 80,600 | SEC↗ |
| Silberstein Charles | Chief Financial Officer | A Award | 2021-12-14 | 2021-12-16 | 47,900 | — | $0 | 135,703 | SEC↗ |
| Hansard Adam | Chief Commercial Officer | A Award | 2021-12-14 | 2021-12-16 | 31,700 | — | $0 | 65,270 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | A Award | 2021-12-14 | 2021-12-16 | 48,200 | — | $0 | 48,200 | SEC↗ |
| Shendelman Shoshana | President and CEO | A Award | 2021-12-14 | 2021-12-16 | 120,900 | — | $0 | 485,186 | SEC↗ |
| Shendelman Shoshana | President and CEO | P Buy | 2021-09-14 | 2021-09-14 | 9,300 | $14.49 | $134.8K | 364,286 | SEC↗ |
| Shendelman Shoshana | President and CEO | P Buy | 2021-09-13 | 2021-09-14 | 701 | $14.69 | $10.3K | 354,986 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-08-10 | 2021-08-11 | 8,873 | — | $0 | 94,874 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-08-10 | 2021-08-11 | 800 | $16.35 | $13.1K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-08-10 | 2021-08-11 | 8,273 | $15.85 | $131.1K | 600 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-08-10 | 2021-08-11 | 8,873 | $1.44 | $12.8K | 8,873 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-08-09 | 2021-08-11 | 15,000 | — | $0 | 103,747 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-08-09 | 2021-08-11 | 4,700 | $17.85 | $83.9K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-08-09 | 2021-08-11 | 10,300 | $17.18 | $177.0K | 4,700 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-08-09 | 2021-08-11 | 15,000 | $1.44 | $21.6K | 15,000 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-07-29 | 2021-07-29 | 15,000 | — | $0 | 118,747 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-07-29 | 2021-07-29 | 15,000 | $17.18 | $257.7K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-07-29 | 2021-07-29 | 15,000 | $1.44 | $21.6K | 15,000 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-07-28 | 2021-07-29 | 15,000 | — | $0 | 133,747 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-07-28 | 2021-07-29 | 15,000 | $1.44 | $21.6K | 15,000 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-07-28 | 2021-07-29 | 15,000 | $17.50 | $262.5K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-07-27 | 2021-07-29 | 15,000 | — | $0 | 148,747 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-07-27 | 2021-07-29 | 7,776 | $17.05 | $132.6K | 7,224 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-07-27 | 2021-07-29 | 7,224 | $17.39 | $125.6K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-07-27 | 2021-07-29 | 15,000 | $1.44 | $21.6K | 15,000 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-07-15 | 2021-07-15 | 460 | — | $0 | 163,747 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-07-15 | 2021-07-15 | 460 | $19.54 | $9.0K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-07-15 | 2021-07-15 | 460 | $1.44 | $662 | 460 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-07-14 | 2021-07-15 | 460 | — | $0 | 164,207 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-07-14 | 2021-07-15 | 460 | $1.44 | $662 | 460 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-07-14 | 2021-07-15 | 460 | $20.51 | $9.4K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-07-13 | 2021-07-15 | 460 | — | $0 | 164,667 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-07-13 | 2021-07-15 | 460 | $1.44 | $662 | 460 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-07-13 | 2021-07-15 | 460 | $21.25 | $9.8K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-06-30 | 2021-06-30 | 460 | — | $0 | 165,127 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-06-30 | 2021-06-30 | 460 | $1.44 | $662 | 460 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-06-30 | 2021-06-30 | 160 | $20.80 | $3.3K | 300 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-06-30 | 2021-06-30 | 300 | $21.71 | $6.5K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-06-29 | 2021-06-30 | 460 | — | $0 | 165,587 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-06-29 | 2021-06-30 | 460 | $1.44 | $662 | 460 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-06-29 | 2021-06-30 | 460 | $21.76 | $10.0K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise deriv | 2021-06-28 | 2021-06-30 | 3,547 | — | $0 | 166,047 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-06-28 | 2021-06-30 | 1,200 | $24.01 | $28.8K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-06-28 | 2021-06-30 | 1,987 | $23.51 | $46.7K | 1,200 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-06-28 | 2021-06-30 | 360 | $21.96 | $7.9K | 3,187 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-06-28 | 2021-06-30 | 3,547 | $1.44 | $5.1K | 3,547 | SEC↗ |
| Silberstein Charles | Chief Financial Officer | S Sale | 2021-06-08 | 2021-06-10 | 5,047 | $21.42 | $108.1K | 87,803 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-06-07 | 2021-06-07 | 260 | $21.38 | $5.6K | 0 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | S Sale | 2021-06-07 | 2021-06-07 | 200 | $20.43 | $4.1K | 260 | SEC↗ |
| Perfetti Riccardo | Chief Medical Officer | M Exercise | 2021-06-07 | 2021-06-07 | 460 | $1.44 | $662 | 460 | SEC↗ |